166 related articles for article (PubMed ID: 18378715)
1. Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.
Allegaert K; Scheers I; Adams E; Brajanoski G; Cossey V; Anderson BJ
Antimicrob Agents Chemother; 2008 Jun; 52(6):1934-9. PubMed ID: 18378715
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.
Gaillard JL; Silly C; Le Masne A; Mahut B; Lacaille F; Cheron G; Abadie V; Hubert P; Matha V; Coustere C
Antimicrob Agents Chemother; 1995 Jan; 39(1):253-5. PubMed ID: 7695318
[TBL] [Abstract][Full Text] [Related]
3. Effect of delay in analysis on neonatal cerebrospinal fluid parameters.
Rajesh NT; Dutta S; Prasad R; Narang A
Arch Dis Child Fetal Neonatal Ed; 2010 Jan; 95(1):F25-9. PubMed ID: 19671531
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid values in very low birth weight infants with suspected sepsis at different ages.
Mhanna MJ; Alesseh H; Gori A; Aziz HF
Pediatr Crit Care Med; 2008 May; 9(3):294-8. PubMed ID: 18446114
[TBL] [Abstract][Full Text] [Related]
6. Determination of amikacin in cerebrospinal fluid by high-performance liquid chromatography with pulsed electrochemical detection.
Brajanoski G; Hoogmartens J; Allegaert K; Adams E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):149-52. PubMed ID: 18396112
[TBL] [Abstract][Full Text] [Related]
7. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM
Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of amikacin in neonates.
Padovani EM; Pistolesi C; Fanos V; Messori A; Martini N
Dev Pharmacol Ther; 1993; 20(3-4):167-73. PubMed ID: 7828449
[TBL] [Abstract][Full Text] [Related]
9. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?
Garges HP; Moody MA; Cotten CM; Smith PB; Tiffany KF; Lenfestey R; Li JS; Fowler VG; Benjamin DK
Pediatrics; 2006 Apr; 117(4):1094-100. PubMed ID: 16585303
[TBL] [Abstract][Full Text] [Related]
10. Reference range for cerebrospinal fluid values in neonates: 5-year retrospective study.
Gunti S; Nair V; Kannan Loganathan P
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10584-10590. PubMed ID: 36310086
[TBL] [Abstract][Full Text] [Related]
11. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.
Maniu CV; Hellinger WC; Chu SY; Palmer R; Alvarez-Elcoro S
Clin Infect Dis; 2001 Sep; 33(5):745-8. PubMed ID: 11486298
[TBL] [Abstract][Full Text] [Related]
12. Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study.
Shokouhi S; Alavi Darazam I
J Infect; 2014 Nov; 69(5):424-9. PubMed ID: 24973553
[TBL] [Abstract][Full Text] [Related]
13. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K
J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740
[TBL] [Abstract][Full Text] [Related]
14. Limited predictability of amikacin clearance in extreme premature neonates at birth.
Allegaert K; Anderson BJ; Cossey V; Holford NH
Br J Clin Pharmacol; 2006 Jan; 61(1):39-48. PubMed ID: 16390350
[TBL] [Abstract][Full Text] [Related]
15. Lumbar puncture in the neonate: challenges in decision making and interpretation.
Srinivasan L; Harris MC; Shah SS
Semin Perinatol; 2012 Dec; 36(6):445-53. PubMed ID: 23177804
[TBL] [Abstract][Full Text] [Related]
16. [A pharmacokinetic basis for schedules for administering amikacin to newborn infants].
Firsov AA; Sudilovskaia NN; Strachunskiĭ LS
Pediatriia; 1991; (8):33-8. PubMed ID: 1762854
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of amikacin in preterm and term infants.
Siddiqi A; Khan DA; Khan FA; Razzaq A
Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
[TBL] [Abstract][Full Text] [Related]
18. Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children.
Tréluyer JM; Merlé Y; Tonnelier S; Rey E; Pons G
Antimicrob Agents Chemother; 2002 May; 46(5):1381-7. PubMed ID: 11959572
[TBL] [Abstract][Full Text] [Related]
19. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.
Avedissian SN; Pais G; Joshi MD; Rhodes NJ; Scheetz MH
mSphere; 2019 Jan; 4(1):. PubMed ID: 30700511
[TBL] [Abstract][Full Text] [Related]
20. [Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].
Rutkowska M; Kamińska E; Piekarczyk A; Nowicka K; Polak K; Nowakowska-Szyrwińska E; Szamotulska K
Med Wieku Rozwoj; 2009; 13(4):252-9. PubMed ID: 20081273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
